PubMed:32149769 / 1711-1845 JSONTXT

{"project":"LitCovid-PAS-Enju","denotations":[{"id":"EnjuParser_T253","span":{"begin":0,"end":3},"obj":"NNP"},{"id":"EnjuParser_T254","span":{"begin":4,"end":16},"obj":"VBD"},{"id":"EnjuParser_T255","span":{"begin":17,"end":20},"obj":"DT"},{"id":"EnjuParser_T256","span":{"begin":21,"end":25},"obj":"RBS"},{"id":"EnjuParser_T257","span":{"begin":26,"end":32},"obj":"JJ"},{"id":"EnjuParser_T258","span":{"begin":33,"end":43},"obj":"NN"},{"id":"EnjuParser_T259","span":{"begin":44,"end":46},"obj":"IN"},{"id":"EnjuParser_T260","span":{"begin":47,"end":53},"obj":"NN"},{"id":"EnjuParser_T261","span":{"begin":54,"end":63},"obj":"NN"},{"id":"EnjuParser_T262","span":{"begin":63,"end":64},"obj":"-COMMA-"},{"id":"EnjuParser_T263","span":{"begin":65,"end":69},"obj":"IN"},{"id":"EnjuParser_T264","span":{"begin":70,"end":71},"obj":"DT"},{"id":"EnjuParser_T265","span":{"begin":72,"end":85},"obj":"NN"},{"id":"EnjuParser_T266","span":{"begin":86,"end":89},"obj":"IN"},{"id":"EnjuParser_T267","span":{"begin":90,"end":92},"obj":"CD"},{"id":"EnjuParser_T268","span":{"begin":92,"end":93},"obj":"NN"},{"id":"EnjuParser_T269","span":{"begin":94,"end":96},"obj":"IN"},{"id":"EnjuParser_T270","span":{"begin":97,"end":104},"obj":"JJ"},{"id":"EnjuParser_T271","span":{"begin":105,"end":111},"obj":"NN"},{"id":"EnjuParser_T272","span":{"begin":112,"end":113},"obj":"-LRB-"},{"id":"EnjuParser_T273","span":{"begin":113,"end":117},"obj":"NN"},{"id":"EnjuParser_T274","span":{"begin":117,"end":118},"obj":"-RRB-"},{"id":"EnjuParser_T275","span":{"begin":119,"end":121},"obj":"IN"},{"id":"EnjuParser_T276","span":{"begin":122,"end":126},"obj":"CD"},{"id":"EnjuParser_T277","span":{"begin":127,"end":134},"obj":"NNP"}],"relations":[{"id":"EnjuParser_R249","pred":"arg2Of","subj":"EnjuParser_T258","obj":"EnjuParser_T254"},{"id":"EnjuParser_R250","pred":"arg1Of","subj":"EnjuParser_T258","obj":"EnjuParser_T255"},{"id":"EnjuParser_R251","pred":"arg1Of","subj":"EnjuParser_T257","obj":"EnjuParser_T256"},{"id":"EnjuParser_R252","pred":"arg1Of","subj":"EnjuParser_T258","obj":"EnjuParser_T257"},{"id":"EnjuParser_R253","pred":"arg1Of","subj":"EnjuParser_T258","obj":"EnjuParser_T259"},{"id":"EnjuParser_R254","pred":"arg2Of","subj":"EnjuParser_T261","obj":"EnjuParser_T259"},{"id":"EnjuParser_R255","pred":"arg1Of","subj":"EnjuParser_T261","obj":"EnjuParser_T260"},{"id":"EnjuParser_R256","pred":"arg1Of","subj":"EnjuParser_T254","obj":"EnjuParser_T262"},{"id":"EnjuParser_R257","pred":"arg1Of","subj":"EnjuParser_T254","obj":"EnjuParser_T263"},{"id":"EnjuParser_R258","pred":"arg2Of","subj":"EnjuParser_T265","obj":"EnjuParser_T263"},{"id":"EnjuParser_R259","pred":"arg1Of","subj":"EnjuParser_T265","obj":"EnjuParser_T264"},{"id":"EnjuParser_R260","pred":"arg1Of","subj":"EnjuParser_T265","obj":"EnjuParser_T266"},{"id":"EnjuParser_R261","pred":"arg2Of","subj":"EnjuParser_T268","obj":"EnjuParser_T266"},{"id":"EnjuParser_R262","pred":"arg1Of","subj":"EnjuParser_T268","obj":"EnjuParser_T267"},{"id":"EnjuParser_R263","pred":"arg1Of","subj":"EnjuParser_T268","obj":"EnjuParser_T269"},{"id":"EnjuParser_R264","pred":"arg2Of","subj":"EnjuParser_T271","obj":"EnjuParser_T269"},{"id":"EnjuParser_R265","pred":"arg1Of","subj":"EnjuParser_T271","obj":"EnjuParser_T270"},{"id":"EnjuParser_R266","pred":"arg1Of","subj":"EnjuParser_T271","obj":"EnjuParser_T272"},{"id":"EnjuParser_R267","pred":"arg2Of","subj":"EnjuParser_T273","obj":"EnjuParser_T272"},{"id":"EnjuParser_R268","pred":"arg3Of","subj":"EnjuParser_T274","obj":"EnjuParser_T272"}],"text":"CEP demonstrated the most potent inhibition of GX_P2V infection, with a concentration for 50% of maximal effect [EC50] of 0.98 μmol/L."}

{"project":"LitCovid-ArguminSci","denotations":[{"id":"T13","span":{"begin":0,"end":134},"obj":"DRI_Outcome"}],"text":"CEP demonstrated the most potent inhibition of GX_P2V infection, with a concentration for 50% of maximal effect [EC50] of 0.98 μmol/L."}

{"project":"LitCovid-PubTatorCentral","denotations":[{"id":"T7","span":{"begin":54,"end":63},"obj":"Disease:MESH:D007239"}],"text":"CEP demonstrated the most potent inhibition of GX_P2V infection, with a concentration for 50% of maximal effect [EC50] of 0.98 μmol/L."}

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T16","span":{"begin":0,"end":134},"obj":"Sentence"}],"text":"CEP demonstrated the most potent inhibition of GX_P2V infection, with a concentration for 50% of maximal effect [EC50] of 0.98 μmol/L."}

{"project":"LitCovid-TimeML","denotations":[{"id":"tok322","span":{"begin":0,"end":3},"obj":"NNP"},{"id":"tok323","span":{"begin":4,"end":16},"obj":"VBD"},{"id":"tok324","span":{"begin":17,"end":20},"obj":"DT"},{"id":"tok325","span":{"begin":21,"end":25},"obj":"RBS"},{"id":"tok326","span":{"begin":26,"end":32},"obj":"JJ"},{"id":"tok327","span":{"begin":33,"end":43},"obj":"NN"},{"id":"tok328","span":{"begin":44,"end":46},"obj":"IN"},{"id":"tok329","span":{"begin":47,"end":49},"obj":"NNP"},{"id":"tok330","span":{"begin":49,"end":50},"obj":"NN"},{"id":"tok331","span":{"begin":50,"end":51},"obj":"NN"},{"id":"tok332","span":{"begin":51,"end":52},"obj":"CD"},{"id":"tok333","span":{"begin":52,"end":53},"obj":"NNP"},{"id":"tok334","span":{"begin":54,"end":63},"obj":"NN"},{"id":"tok335","span":{"begin":63,"end":64},"obj":","},{"id":"tok336","span":{"begin":65,"end":69},"obj":"IN"},{"id":"tok337","span":{"begin":70,"end":71},"obj":"DT"},{"id":"tok338","span":{"begin":72,"end":85},"obj":"NN"},{"id":"tok339","span":{"begin":86,"end":89},"obj":"IN"},{"id":"tok340","span":{"begin":90,"end":92},"obj":"CD"},{"id":"tok341","span":{"begin":92,"end":93},"obj":"NN"},{"id":"tok342","span":{"begin":94,"end":96},"obj":"IN"},{"id":"tok343","span":{"begin":97,"end":104},"obj":"NN"},{"id":"tok344","span":{"begin":105,"end":111},"obj":"NN"},{"id":"tok345","span":{"begin":112,"end":113},"obj":"NN"},{"id":"tok346","span":{"begin":113,"end":115},"obj":"NNP"},{"id":"tok347","span":{"begin":115,"end":117},"obj":"CD"},{"id":"tok348","span":{"begin":117,"end":118},"obj":"NN"},{"id":"tok349","span":{"begin":119,"end":121},"obj":"IN"},{"id":"tok350","span":{"begin":122,"end":123},"obj":"CD"},{"id":"tok351","span":{"begin":123,"end":124},"obj":"."},{"id":"tok352","span":{"begin":124,"end":126},"obj":"CD"},{"id":"tok353","span":{"begin":127,"end":131},"obj":"NN"},{"id":"tok354","span":{"begin":131,"end":132},"obj":"NN"},{"id":"tok355","span":{"begin":132,"end":133},"obj":"NNP"},{"id":"tok356","span":{"begin":133,"end":134},"obj":"."},{"id":"lookup41","span":{"begin":0,"end":3},"obj":"organization"},{"id":"lookup42","span":{"begin":92,"end":93},"obj":"percent"},{"id":"lookup43","span":{"begin":113,"end":115},"obj":"organization"},{"id":"event4","span":{"begin":4,"end":16},"obj":"OCCURRENCE"}],"text":"CEP demonstrated the most potent inhibition of GX_P2V infection, with a concentration for 50% of maximal effect [EC50] of 0.98 μmol/L."}

{"project":"LitCovid-PD-MONDO-v1","denotations":[{"id":"T11","span":{"begin":0,"end":3},"obj":"Disease"},{"id":"T12","span":{"begin":54,"end":63},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0009902"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"CEP demonstrated the most potent inhibition of GX_P2V infection, with a concentration for 50% of maximal effect [EC50] of 0.98 μmol/L."}